Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer's disease.

Le Droumaguet B, Nicolas J, Brambilla D, Mura S, Maksimenko A, De Kimpe L, Salvati E, Zona C, Airoldi C, Canovi M, Gobbi M, Magali N, La Ferla B, Nicotra F, Scheper W, Flores O, Masserini M, Andrieux K, Couvreur P.

ACS Nano. 2012 Jul 24;6(7):5866-79. doi: 10.1021/nn3004372. Epub 2012 Jul 2.

PMID:
22725248
2.

Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization.

Le Droumaguet B, Souguir H, Brambilla D, Verpillot R, Nicolas J, Taverna M, Couvreur P, Andrieux K.

Int J Pharm. 2011 Sep 20;416(2):453-60. doi: 10.1016/j.ijpharm.2011.01.015. Epub 2011 Jan 18.

PMID:
21251960
3.

PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer's disease.

Brambilla D, Verpillot R, Le Droumaguet B, Nicolas J, Taverna M, Kóňa J, Lettiero B, Hashemi SH, De Kimpe L, Canovi M, Gobbi M, Nicolas V, Scheper W, Moghimi SM, Tvaroška I, Couvreur P, Andrieux K.

ACS Nano. 2012 Jul 24;6(7):5897-908. doi: 10.1021/nn300489k. Epub 2012 Jun 19.

PMID:
22686577
4.

Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.

Kulkarni PV, Roney CA, Antich PP, Bonte FJ, Raghu AV, Aminabhavi TM.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 Jan-Feb;2(1):35-47. doi: 10.1002/wnan.59. Review.

PMID:
20049829
5.

Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.

Essa S, Rabanel JM, Hildgen P.

Int J Pharm. 2011 Jun 15;411(1-2):178-87. doi: 10.1016/j.ijpharm.2011.02.039. Epub 2011 Mar 31.

PMID:
21458551
6.

New method based on capillary electrophoresis with laser-induced fluorescence detection (CE-LIF) to monitor interaction between nanoparticles and the amyloid-β peptide.

Brambilla D, Verpillot R, Taverna M, De Kimpe L, Le Droumaguet B, Nicolas J, Canovi M, Gobbi M, Mantegazza F, Salmona M, Nicolas V, Scheper W, Couvreur P, Andrieux K.

Anal Chem. 2010 Dec 15;82(24):10083-9. doi: 10.1021/ac102045x. Epub 2010 Nov 18.

PMID:
21086977
7.

Click chemistry functionalized polymeric nanoparticles target corneal epithelial cells through RGD-cell surface receptors.

Lu J, Shi M, Shoichet MS.

Bioconjug Chem. 2009 Jan;20(1):87-94. doi: 10.1021/bc8003167.

PMID:
19099361
8.

Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.

Brambilla D, Le Droumaguet B, Nicolas J, Hashemi SH, Wu LP, Moghimi SM, Couvreur P, Andrieux K.

Nanomedicine. 2011 Oct;7(5):521-40. doi: 10.1016/j.nano.2011.03.008. Epub 2011 Apr 6. Review.

PMID:
21477665
9.

Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.

Yang X, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Matson VZ, Steeber DA, Gong S.

ACS Nano. 2010 Nov 23;4(11):6805-17. doi: 10.1021/nn101670k. Epub 2010 Oct 19.

PMID:
20958084
10.

Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide.

Gobbi M, Re F, Canovi M, Beeg M, Gregori M, Sesana S, Sonnino S, Brogioli D, Musicanti C, Gasco P, Salmona M, Masserini ME.

Biomaterials. 2010 Sep;31(25):6519-29. doi: 10.1016/j.biomaterials.2010.04.044.

PMID:
20553982
11.

A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery.

Liu Y, Li K, Liu B, Feng SS.

Biomaterials. 2010 Dec;31(35):9145-55. doi: 10.1016/j.biomaterials.2010.08.053. Epub 2010 Sep 22.

PMID:
20864169
12.

Increasing entrapment of peptides within poly(alkyl cyanoacrylate) nanoparticles prepared from water-in-oil microemulsions by copolymerization.

Liang M, Davies NM, Toth I.

Int J Pharm. 2008 Oct 1;362(1-2):141-6. doi: 10.1016/j.ijpharm.2008.06.005. Epub 2008 Jun 13.

PMID:
18598746
13.

Surface-modified protein microspheres capture amyloid-β and inhibit its aggregation and toxicity.

Richman M, Wilk S, Skirtenko N, Perelman A, Rahimipour S.

Chemistry. 2011 Sep 26;17(40):11171-7. doi: 10.1002/chem.201101326. Epub 2011 Sep 2.

PMID:
21887833
14.

Furan-functionalized co-polymers for targeted drug delivery: characterization, self-assembly and drug encapsulation.

Shi M, Shoichet MS.

J Biomater Sci Polym Ed. 2008;19(9):1143-57. doi: 10.1163/156856208785540127.

PMID:
18727857
15.

Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.

Jiang X, Sha X, Xin H, Chen L, Gao X, Wang X, Law K, Gu J, Chen Y, Jiang Y, Ren X, Ren Q, Fang X.

Biomaterials. 2011 Dec;32(35):9457-69. doi: 10.1016/j.biomaterials.2011.08.055. Epub 2011 Sep 10.

PMID:
21911250
16.

Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide.

Taylor M, Moore S, Mourtas S, Niarakis A, Re F, Zona C, La Ferla B, Nicotra F, Masserini M, Antimisiaris SG, Gregori M, Allsop D.

Nanomedicine. 2011 Oct;7(5):541-50. doi: 10.1016/j.nano.2011.06.015. Epub 2011 Jun 29.

PMID:
21722618
17.

Nanoparticles against Alzheimer's disease: PEG-PACA nanoparticles are able to link the aβ-peptide and influence its aggregation kinetic.

Brambilla D, Verpillot R, De Kimpe L, Taverna M, Le Droumaguet B, Nicolas J, Canovi M, Gobbi M, Salmona M, Nicolas V, Scheper W, Couvreur P, Andrieux K.

J Control Release. 2010 Nov 20;148(1):e112-3. doi: 10.1016/j.jconrel.2010.07.084. No abstract available.

PMID:
21529583
18.

An effector-reduced anti-β-amyloid (Aβ) antibody with unique aβ binding properties promotes neuroprotection and glial engulfment of Aβ.

Adolfsson O, Pihlgren M, Toni N, Varisco Y, Buccarello AL, Antoniello K, Lohmann S, Piorkowska K, Gafner V, Atwal JK, Maloney J, Chen M, Gogineni A, Weimer RM, Mortensen DL, Friesenhahn M, Ho C, Paul R, Pfeifer A, Muhs A, Watts RJ.

J Neurosci. 2012 Jul 11;32(28):9677-89. doi: 10.1523/JNEUROSCI.4742-11.2012.

19.

Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.

Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong S.

Biomaterials. 2009 Oct;30(30):6065-75. doi: 10.1016/j.biomaterials.2009.07.048. Epub 2009 Aug 12.

PMID:
19674777
20.

Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.

Sant S, Poulin S, Hildgen P.

J Biomed Mater Res A. 2008 Dec 15;87(4):885-95. doi: 10.1002/jbm.a.31800.

PMID:
18228249

Supplemental Content

Support Center